Efficacy and safety of nab-paclitaxel in patients with metastatic breast cancer: Final results of the non-interventional study NABUCCO

被引：0
|
作者：
Marschner, N.
Potthoff, K. [1 ]
Salat, C.
Soeling, U.
Hansen, R.
Grebhardt, S. [1 ]
Horde, J. [1 ]
Nusch, A.
机构：
[1] iOMEDICO AG, Freiburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P598
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [41] Phase II trial of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
    Yizhao Xie
    Chengcheng Gong
    Jian Zhang
    Leiping Wang
    Jun Cao
    Zhonghua Tao
    Ting Li
    Yannan Zhao
    Yi Li
    Shihui Hu
    Biyun Wang
    Xichun Hu
    BMC Cancer, 21
  • [42] Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer
    Borazanci, Erkut
    Von Hoff, Daniel D.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 739 - 747
  • [43] Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile
    Gonzalez-Martin, Antonio
    Alba, Emilio
    Ciruelos, Eva
    Cortes, Javier
    Llombart, Antonio
    Lluch, Ana
    Andres, Raquel
    Alvarez, Isabel
    Manuel Aramenda, Jose
    Ayala de la Pena, Francisco
    Barnadas, Agusti
    Batista, Norberto
    Calvo, Lourdes
    Galve, Elena
    Garcia-Palomo, Andres
    Angel Garcia-Saenz, Jose
    de la Haba, Juan
    Lopez, Rafael
    Lopez-Vivanco, Guillermo
    Martinez-Janez, Noelia
    Martinez de Duenas, Eduardo
    Plazaola, Arrate
    Rodriguez-Lescure, Alvaro
    Ruiz, Manuel
    Sanchez-Rovira, Pedro
    Santaballa, Ana
    Angel Segui, Miguel
    Tusquets, Ignasi
    Zamora, Pilar
    Martin, Miguel
    CURRENT CANCER DRUG TARGETS, 2016, 16 (05) : 415 - 428
  • [44] Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study
    Arpino, Grazia
    De Placido, Sabino
    De Angelis, Carmine
    ANTI-CANCER DRUGS, 2015, 26 (01) : 117 - 122
  • [45] Nab-paclitaxel (nab-P) in metastatic breast cancer (MBC) in elderly patients: A real life setting (NEREIDE study)
    Adamo, V.
    Ricciardi, G. R. R.
    Schifano, S.
    Russo, A.
    Gebbia, V.
    Blasi, L.
    Giuffrida, D.
    Scandurra, G.
    Savarino, A.
    Butera, A.
    Borsellino, N.
    Verderame, F.
    Caruso, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [46] Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
    Lobo, Christopher
    Lopes, Gilberto
    Baez, Odalys
    Castrellon, Aurelio
    Ferrell, Annapoorna
    Higgins, Connie
    Hurley, Erin
    Hurley, Judith
    Reis, Isildinha
    Richman, Stephen
    Seo, Pearl
    Silva, Orlando
    Slingerland, Joyce
    Tukia, Keleni
    Welsh, Catherine
    Glueck, Stefan
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (02) : 427 - 435
  • [47] Expression of SPARC and response to nab-paclitaxel (nab-p) in patients (pts) with metastatic breast cancer (MBC)
    Schneeweiss, Andreas
    Aigner, Julia
    Smetanay, Katherina
    Schuetz, Florian
    Sohn, Christof
    Kriegsmann, Mark
    Jaeger, Dirk
    Zorn, Markus
    Bachinger, Andreas
    Sinn, Hans-Peter
    Marme, Frederik
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
    Christopher Lobo
    Gilberto Lopes
    Odalys Baez
    Aurelio Castrellon
    Annapoorna Ferrell
    Connie Higgins
    Erin Hurley
    Judith Hurley
    Isildinha Reis
    Stephen Richman
    Pearl Seo
    Orlando Silva
    Joyce Slingerland
    Keleni Tukia
    Catherine Welsh
    Stefan Glück
    Breast Cancer Research and Treatment, 2010, 123 : 427 - 435
  • [49] Evaluation of Efficacy and Safety of Nab-Paclitaxel vs Paclitaxel in Platinum-Refractory Metastatic Urothelial Cancer-Reply
    Funada, Satoshi
    Yoshioka, Takashi
    Luo, Yan
    JAMA ONCOLOGY, 2021, 7 (04) : 634 - +
  • [50] Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer
    Rapposelli, Ilario Giovanni
    Casadei-Gardini, Andrea
    Vivaldi, Caterina
    Bartolini, Giulia
    Bernardini, Laura
    Passardi, Alessandro
    Frassineti, Giovanni Luca
    Massa, Valentina
    Cucchetti, Alessandro
    BIOMOLECULES, 2021, 11 (06)
12345